Atlas Trials

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Clinical trial NCT05296421 · RECRUITING

Trial details

NCT number
NCT05296421
Sponsor
Rutgers, The State University of New Jersey
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2022-03-14
Primary completion
2027-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.